Document is current

Article History

Received: 19 June 2024

Accepted: 25 October 2024

First Online: 5 December 2024

Declarations

:

: Corinne Young is an employee of the Association of Pulmonary Advanced Practice Providers and Clinical Services. Lydia Y. Lee was a university worker hired by GSK at the time of this study. Lydia Y. Lee is currently an employee of Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA (Boehringer Ingelheim has no connection to this study). Kristi K. DiRocco, Stephen G. Noorduyn, and Rosirene Paczkowski are employees of GSK and hold financial equities in GSK. Stephen G. Noorduyn is also a PhD candidate at McMaster University, Hamilton, ON, Canada. Guillaume Germain, Jacob Klimek, François Laliberté, and Dominique Lejeune are employees of Groupe d'analyse, Ltée, Montréal, QC, Canada, which received funding from GSK to conduct this study.

: The data reported in this publication are contained in a database owned by IQVIA and contain proprietary elements. Therefore, these data cannot be broadly disclosed or made publicly available at this time. The disclosure of this data to third-party clients assumes certain data security and privacy protocols are in place and that the third-party client has executed IQVIA’s standard license agreement, which includes restrictive covenants governing the use of the data. Permission was obtained from IQVIA to use the data. This study complied with all applicable laws regarding subject privacy. No direct subject contact or primary collection of individual human subject data occurred in this study. This study used existing, fully de-identified data that complied with the requirements of the Health Insurance Portability and Accountability Act, and the subject(s) cannot be identified, directly or through identifiers. The study results are in tabular form and aggregate analyses that omit subject identification. As per Title 45 of CFR, Part 46 (), informed consent, ethics committee, or institutional review board review were not needed, as the claims data analysis of our study was a retrospective analysis of existing data (hence no patient intervention or interaction), and no patient-identifiable information was included in the claims dataset.